Facial Changes After GLP-1 Weight Loss — What Actually Helps “Ozempic Face”

You lost the weight. Why does your face look older?

It’s one of the most common — and least discussed — experiences our weight loss patients describe: the scale says success, but the mirror shows a face that looks deflated, hollowed, or suddenly older. The phenomenon has a popular name, “Ozempic face,” and it’s now the subject of a growing medical literature, including a 2025 systematic review documenting the exaggerated facial volume loss that can accompany GLP-1–driven weight loss. As a medical practice that has guided thousands of patients through semaglutide and tirzepatide treatment, we’d rather explain honestly what’s happening — and what each treatment can and cannot do about it — than sell you a one-size-fits-all fix.

What’s actually happening to your face

Facial fat isn’t just “weight” — it’s structural. Distinct fat compartments support the skin, round out the cheeks and temples, and smooth the transitions between facial regions. When weight comes off quickly, those compartments deflate along with the rest of your body fat. A 2026 anatomical review describes the pattern: deflation of the superficial fat compartments (especially in the midface), reduced deep support, and increased skin laxity — flattening contours and making transition lines more pronounced. Clinical estimates cited in the ophthalmic-plastics literature suggest roughly 7% of midfacial volume is lost for every 10 kilograms (about 22 pounds) of weight lost. Importantly, this isn’t a drug side effect in the usual sense — it’s the face’s share of rapid fat loss, the same phenomenon long described after bariatric surgery. Slower weight loss tends to mean gentler facial change, one more reason we favor medically supervised, gradual protocols.

Matching the treatment to the problem

Different tools address different parts of this picture, and honest scoping matters more here than anywhere else in aesthetics:

• Volume loss (hollowing, flattened cheeks): this is the territory of dermal fillers and collagen-stimulating injectables, which the anatomical literature identifies as the evidence-based response to compartment deflation. BeLite does not currently offer fillers — if volume restoration is your priority, we’ll say so plainly and you should see a practice that does.
• Skin laxity (sagging): addressed with skin-tightening technologies or, in significant cases, surgery — also outside what a neurotoxin can do.
• Lines made more prominent by deflation: this is where Xeomin fits. As volume decreases, forehead lines, frown lines, and crow’s feet often stand out more — the skin creases more visibly over thinner support. Relaxing the muscles that create those lines softens one of the most visible components of the post-weight-loss face. It will not re-inflate anything, and we won’t tell you it will.

The whole-picture approach

Because facial change tracks the pace and magnitude of weight loss, the conversation belongs inside your weight loss care, not bolted on afterward. That’s the advantage of addressing it at the practice that manages your GLP-1 treatment: we can moderate the rate of loss, protect muscle and nutrition along the way (see our guides to preserving muscle during GLP-1 treatment and what happens to body composition — [developer: link existing posts]), and time any aesthetic treatment sensibly — usually once weight has stabilized, since a face still changing is a moving target.

FAQ

Does Xeomin treat Ozempic face? It treats one component: the expression lines that volume loss makes more prominent. It does not restore volume — fillers and collagen stimulators address that.

Will my face recover if I stop the medication? Regaining weight regains some facial fat, but that’s not a treatment strategy — it trades away the health benefits you earned. Stabilizing at your goal weight and addressing specific concerns directly is the sounder path.

Can I prevent it? Gradual, supervised weight loss with adequate protein and strength training gives your skin the best chance to adapt. This is a core part of how we run GLP-1 treatment at BeLite.
Book Your Free Consultation
Wondering whether Xeomin is right for you? BeLite Medical Center has served Fairfax and Northern Virginia since 1995. Consultations are free — your provider will develop an individualized treatment plan with you, and if you decide not to proceed, you pay nothing. Schedule online 24/7, or call or text (703) 359-9200.

This article is for general education and is not medical advice. Individual results vary. Talk with a licensed medical provider about whether treatment is appropriate for you. Botox® is a registered trademark of Allergan, an AbbVie company; Xeomin® is a registered trademark of Merz Pharma. BeLite Medical Center is not affiliated with Allergan or AbbVie.

References (verified, hyperlinked)

• Daneshgaran G, Shauly O, Gould DJ. “Ozempic Face” in plastic surgery: a systematic review. Aesthet Surg J Open Forum. 2025;7:ojaf056. PMID 40626110
• GLP-1–induced weight loss and the face: anatomical mechanisms and rationale for collagen-stimulating and volumizing treatments (2026 review). PMID 42210888
• American Academy of Ophthalmology, EyeNet. GLP-1s and rapid facial aging: aesthetic solutions (clinical summary incl. midfacial volume data). org